EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation

Qing Zhang, Chenguang Liu, Sirui Wu, Nan Zhong, Junfeng Qiu, Wei Fu iD, Xujun You

International Journal of Nanomedicine · 2026-07 · Volume 21 · 1-23

DOI: 10.2147/ijn.s614400 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-07. Verfasst von Qing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine Center, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518…. Hauptthemen laut MEDLINE: Triterpenes, Saponins, Prostatic Neoplasms, T-Lymphocytes. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesSaponinsProstatic NeoplasmsT-LymphocytesExosomesScorpion VenomsAptamers, NucleotideAntineoplastic AgentsMaleAnimalsHumansCell Line, TumorMiceApoptosisXenograft Model Antitumor AssaysMice, NudeCell Proliferation

Stichwörter der Autor:innen

Astragaloside IV-PESVantitumor therapyexosome delivery systemprostate cancertumor microenvironment

Substanzen

TriterpenesSaponinsastragaloside AScorpion VenomsAptamers, NucleotideAntineoplastic Agents

Autor:innen und Institutionen

  • Department of General Medicine Center, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518133, People's Republic of China.
  • The Seventh Clinical Medical College of Guangzhou University of Traditional Chinese Medicine, Shenzhen, 518133, People's Republic of China.
  • Department of Andrology, Shenzhen Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518033, People's Republic of China.
  • Department of Andrology, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen, 518133, People's Republic of China.

ORCID-Profile: Wei Fu

Zitieren

APA

Zhang, Q., Liu, C., Wu, S., Zhong, N., Qiu, J., Fu, W., & You, X. (2026). An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation. International Journal of Nanomedicine, Volume 21, 1-23. https://doi.org/10.2147/ijn.s614400

Vancouver

Zhang Q, Liu C, Wu S, Zhong N, Qiu J, Fu W, et al. An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation. International Journal of Nanomedicine. 2026;Volume 21:1-23. doi:10.2147/ijn.s614400

BibTeX
@article{Zhang2026,
  author = {Zhang, Qing and Liu, Chenguang and Wu, Sirui and Zhong, Nan and Qiu, Junfeng and Fu, Wei and You, Xujun},
  title = {An E3 Aptamer-Modified T Cell-Derived Exosomal Nanoplatform for Codelivery of Astragaloside IV and PESV: Enhancing Prostate Cancer Therapy Through Immune Modulation with Implications for Clinical Translation},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--23},
  doi = {10.2147/ijn.s614400}
}
Kostenlos starten →